JP2006504645A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504645A5
JP2006504645A5 JP2004519701A JP2004519701A JP2006504645A5 JP 2006504645 A5 JP2006504645 A5 JP 2006504645A5 JP 2004519701 A JP2004519701 A JP 2004519701A JP 2004519701 A JP2004519701 A JP 2004519701A JP 2006504645 A5 JP2006504645 A5 JP 2006504645A5
Authority
JP
Japan
Prior art keywords
peptide
hcv
antibody
protein
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004519701A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504645A (ja
Filing date
Publication date
Priority claimed from US10/188,608 external-priority patent/US20030180284A1/en
Application filed filed Critical
Publication of JP2006504645A publication Critical patent/JP2006504645A/ja
Publication of JP2006504645A5 publication Critical patent/JP2006504645A5/ja
Pending legal-status Critical Current

Links

JP2004519701A 2002-07-02 2003-06-27 立体構造及び直鎖状エピトープに対する抗体を用いたｈｃｖ感染の予防及び治療 Pending JP2006504645A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/188,608 US20030180284A1 (en) 1998-11-05 2002-07-02 Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes
PCT/US2003/020580 WO2004005316A2 (en) 2002-07-02 2003-06-27 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes

Publications (2)

Publication Number Publication Date
JP2006504645A JP2006504645A (ja) 2006-02-09
JP2006504645A5 true JP2006504645A5 (enExample) 2006-08-17

Family

ID=30114012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004519701A Pending JP2006504645A (ja) 2002-07-02 2003-06-27 立体構造及び直鎖状エピトープに対する抗体を用いたｈｃｖ感染の予防及び治療

Country Status (5)

Country Link
US (1) US20030180284A1 (enExample)
EP (1) EP1572721A4 (enExample)
JP (1) JP2006504645A (enExample)
AU (1) AU2003247841A1 (enExample)
WO (1) WO2004005316A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060188511A1 (en) * 1998-11-05 2006-08-24 Foung Steven K Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes
DE60231475D1 (de) * 2001-01-12 2009-04-23 Molecules Of Man Ab Materialien und methoden zur behandlung von hepatitis c
FR2843115B1 (fr) * 2002-08-02 2007-11-09 Commissariat Energie Atomique Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications
JP2008533114A (ja) * 2005-03-18 2008-08-21 ユーシーエル ビジネス パブリック リミテッド カンパニー メカノ成長因子ペプチドおよびその使用
EP2004684A4 (en) * 2006-03-22 2009-05-06 Genimmune N V THE HEPATITIS C-VIRUS NEUTRALIZING ANTIBODIES
JP5642972B2 (ja) 2007-02-21 2014-12-17 ユニバーシティー オブ マサチューセッツＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ Ｃ型肝炎ウイルス（ｈｃｖ）に対するヒト抗体およびその使用
CN101809033A (zh) 2007-07-25 2010-08-18 日本国立感染症研究所 对丙型肝炎病毒(hcv)感染具有抑制活性的抗体和其用途
WO2010047829A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute Mutant hepatitis c virus e2 polypeptides for hcv treatment
CN102596996B (zh) 2009-10-30 2014-06-18 东丽株式会社 对丙型肝炎病毒(hcv)具有感染抑制活性的抗体及其用途
CA2942540A1 (en) * 2014-03-20 2015-09-24 Takaji Wakita Antibody having infection-inhibiting activity against hepatitis c virus
CN106749645B (zh) * 2016-11-14 2019-12-03 广州泰诺迪生物科技有限公司 一种全人源抗丙型肝炎病毒的中和抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243747T1 (de) * 1991-07-15 2003-07-15 Wellcome Found Herstellung von antikörpern
WO1993006126A1 (en) * 1991-09-13 1993-04-01 Chiron Corporation Immunoreactive hepatitis c virus polypeptide compositions
SG71728A1 (en) * 1994-07-29 2000-04-18 Innogenetics Nv Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
EP0947525A1 (en) * 1998-03-27 1999-10-06 Innogenetics N.V. Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
US6682909B2 (en) * 2000-09-13 2004-01-27 Hawaii Biotech, Inc. Immunogenic composition of hepatitis C and methods of use thereof

Similar Documents

Publication Publication Date Title
US7507408B2 (en) Anti hepatitis C virus antibody and uses thereof
JP3477198B2 (ja) Ｃ型肝炎ウィルス（ｈｃｖ）に対する抗体の検出のためのペプチド及びその混合物
JP3645904B2 (ja) Ｃ型肝炎ウイルスの型の分類方法およびそこで使用する試薬
JPH01500432A (ja) Ａｉｄｓおよびａｒｃのウィルス原因物質に対して免疫化するための組成物および方法
JP2010501594A5 (enExample)
JP2004515202A5 (enExample)
JP2004035534A (ja) Ｈｃｖ抗コア・モノクローナル抗体
WO2001081421A2 (en) Synthetic peptides that bind to the hepatitis b virus core and e antigens
JPH07503614A (ja) Ｈｃｖ蛋白のための哺乳動物発現システム
JPH04253998A (ja) Ｃ型肝炎アッセイ
JP2012504602A5 (enExample)
JP2006504645A5 (enExample)
JP2005531286A (ja) ＨＣＶＥ２グリコプロテインに対して向けられ、ｉｎｖｉｔｒｏ中和活性を有するヒトモノクローナル抗体Ｆａｂ断片
JP2004533991A5 (enExample)
Garcia et al. Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells
JP2000514643A (ja) Ｂ型肝炎表面抗原のａ―決定基の抗原エピトープ及びその利用法
Mattioli et al. Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries
JPH0940694A (ja) 肝炎ｇｂウイルスの合成ペプチド及びその使用
JPWO2007145192A1 (ja) Ｉｖ型コラーゲン様免疫活性ペプチド
CN100588660C (zh) Sars冠状病毒核衣壳蛋白的抗原决定簇及其应用
JP2003502285A (ja) Ｔｔウイルス配列由来のペプチドおよびｔｔウイルスに結合する単一特異性抗体
Polimeno et al. Sub-epitopic dissection of HCV E1315–328HRMAWDMMMNWSPT sequence by similarity analysis
El-Awady et al. Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats
JPS58150518A (ja) Ｂ型肝炎ウイルスのための免疫学的組成物及び方法
WO2005018538A2 (en) Severe acute respiratory syndrome (sars) polypeptides, antibodies to sars polypeptides and the use thereof in diagnostic, vaccination and therapeutic applications